The indigenously developed vaccine, “CERVAVAC” launch took place in the presence o Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Af Serum Institute of India, Prakash K Singh.

The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Affairs at Serum Institute of India, Prakash K Singh. “On the occasion of India’s National Girl Child Day and Cervical Cancer Awareness Month, @Serum Inst India is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon’ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7,” tweeted Adar Poonawalla

Cervavac is India’s first indigenous quadrivalent human papillomavirus (HPV) vaccine. HPV is a group of viruses that can lead to the development of various cancers, including cervical cancer. Cervical cancer is one of the leading causes of cancer-related deaths among women in India.

Cervavac is designed to provide protection against four types of HPV: HPV types 6, 11, 16, and 18. HPV types 16 and 18 are known to cause approximately 70% of cervical cancer cases globally, while types 6 and 11 cause genital warts and recurrent respiratory papillomatosis.

The development and introduction of Cervavac aim to address the significant burden of cervical cancer in India and improve access to HPV vaccination. By offering protection against multiple HPV types, Cervavac has the potential to reduce the incidence of cervical cancer and related diseases.

Cervavac is expected to contribute to India’s efforts to prevent cervical cancer through vaccination programs targeting young girls and women. Vaccination against HPV is recommended before the onset of sexual activity, ideally between the ages of 9 and 14, to maximize its effectiveness in preventing HPV infection and associated diseases.

The introduction of Cervavac represents a crucial step forward in India’s public health initiatives to combat cervical cancer and improve women’s health outcomes. It provides an indigenous solution to address a pressing health issue, offering hope for reducing the burden of cervical cancer and related diseases in the country.